Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Non-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis.

Corey KE, Lai M, Gelrud LG, Misdraji J, Barlow LL, Zheng H, Andersson KL, Thiim M, Pratt DS, Chung RT.

Clin Gastroenterol Hepatol. 2012 Jun;10(6):651-6. doi: 10.1016/j.cgh.2012.01.017. Epub 2012 Feb 10.

2.

Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.

Ampuero J, Ranchal I, Gallego-Durán R, Pareja MJ, Del Campo JA, Pastor-Ramírez H, Rico MC, Picón R, Pastor L, García-Monzón C, Andrade R, Romero-Gómez M.

J Gastroenterol Hepatol. 2016 Sep;31(9):1611-8. doi: 10.1111/jgh.13335.

PMID:
26946071
3.

NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels.

Corey KE, Vuppalanchi R, Wilson LA, Cummings OW, Chalasani N; NASH CRN.

Aliment Pharmacol Ther. 2015 Feb;41(3):301-9. doi: 10.1111/apt.13035. Epub 2014 Nov 28.

4.

Lipoprotein Profiles in Class III Obese Caucasian and African American Women with Nonalcoholic Fatty Liver Disease.

Garcia AE, Kasim N, Tamboli RA, Gonzalez RS, Antoun J, Eckert EA, Marks-Shulman PA, Dunn J, Wattacheril J, Wallen T, Abumrad NN, Flynn CR.

PLoS One. 2015 Nov 23;10(11):e0142676. doi: 10.1371/journal.pone.0142676. eCollection 2015.

5.

De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients.

Idowu MO, Chhatrala R, Siddiqui MB, Driscoll C, Stravitz RT, Sanyal AJ, Bhati C, Sargeant C, Luketic VA, Sterling RK, Contos M, Matherly S, Puri P, Siddiqui MS.

Liver Transpl. 2015 Nov;21(11):1395-402. doi: 10.1002/lt.24223.

6.

Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.

Männistö VT, Simonen M, Soininen P, Tiainen M, Kangas AJ, Kaminska D, Venesmaa S, Käkelä P, Kärjä V, Gylling H, Ala-Korpela M, Pihlajamäki J.

J Lipid Res. 2014 Dec;55(12):2676-84. doi: 10.1194/jlr.P054387. Epub 2014 Oct 24. Erratum in: J Lipid Res. 2016 Apr;57(4):743.

7.

Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease.

Corey KE, Vuppalanchi R, Vos M, Kohli R, Molleston JP, Wilson L, Unalp-Arida A, Cummings OW, Lavine JE, Chalasani N; Nonalcoholic Steatohepatitis Clinical Research Network.

J Pediatr Gastroenterol Nutr. 2015 Mar;60(3):360-7. doi: 10.1097/MPG.0000000000000584.

8.

Non-high-density lipoprotein cholesterol (non-HDL-C) levels in children with nonalcoholic fatty liver disease (NAFLD).

Alkhouri N, Eng K, Lopez R, Nobili V.

Springerplus. 2014 Aug 5;3:407. doi: 10.1186/2193-1801-3-407. eCollection 2014.

9.

Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease.

Sonmez A, Nikolic D, Dogru T, Ercin CN, Genc H, Cesur M, Tapan S, Karslioğlu Y, Montalto G, Banach M, Toth PP, Bagci S, Rizzo M.

J Clin Lipidol. 2015 Jul-Aug;9(4):576-82. doi: 10.1016/j.jacl.2015.03.010. Epub 2015 Apr 4.

PMID:
26228676
10.

Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH.

Boga S, Koksal AR, Alkim H, Yilmaz Ozguven MB, Bayram M, Ergun M, Sisman G, Tekin Neijmann S, Alkim C.

Metab Syndr Relat Disord. 2015 Nov;13(9):393-9. doi: 10.1089/met.2015.0046. Epub 2015 Sep 14.

PMID:
26367098
11.

Serum lipids, lipoproteins and apolipoproteins levels in patients with nonalcoholic steatohepatitis.

Koruk M, Savaş MC, Yilmaz O, Tayşi S, Karakok M, Gündoğdu C, Yilmaz A.

J Clin Gastroenterol. 2003 Aug;37(2):177-82.

PMID:
12869892
12.

Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study.

Smits LP, Coolen BF, Panno MD, Runge JH, Nijhof WH, Verheij J, Nieuwdorp M, Stoker J, Beuers UH, Nederveen AJ, Stroes ES.

Radiology. 2016 Mar;278(3):782-91. doi: 10.1148/radiol.2015150952. Epub 2015 Sep 7.

PMID:
26348104
13.

The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk.

Alkhouri N, Tamimi TA, Yerian L, Lopez R, Zein NN, Feldstein AE.

Dig Dis Sci. 2010 Sep;55(9):2644-50. doi: 10.1007/s10620-009-1075-y. Epub 2009 Dec 5.

PMID:
19960252
14.

Irisin in patients with nonalcoholic fatty liver disease.

Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS.

Metabolism. 2014 Feb;63(2):207-17. doi: 10.1016/j.metabol.2013.09.013. Epub 2013 Oct 18.

PMID:
24140091
15.

The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.

Pennell P, Leclercq B, Delahunty MI, Walters BA.

Clin Nephrol. 2006 Nov;66(5):336-47.

PMID:
17140163
16.

Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study.

Bedossa P, Moucari R, Chelbi E, Asselah T, Paradis V, Vidaud M, Cazals-Hatem D, Boyer N, Valla D, Marcellin P.

Hepatology. 2007 Aug;46(2):380-7.

PMID:
17659580
17.

Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans.

Männistö VT, Simonen M, Hyysalo J, Soininen P, Kangas AJ, Kaminska D, Matte AK, Venesmaa S, Käkelä P, Kärjä V, Arola J, Gylling H, Cederberg H, Kuusisto J, Laakso M, Yki-Järvinen H, Ala-Korpela M, Pihlajamäki J.

Liver Int. 2015 Jul;35(7):1853-61. doi: 10.1111/liv.12769. Epub 2015 Jan 20.

PMID:
25533197
18.
19.

N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis.

Blomme B, Francque S, Trépo E, Libbrecht L, Vanderschaeghe D, Verrijken A, Pattyn P, Nieuwenhove YV, Putte DV, Geerts A, Colle I, Delanghe J, Moreno C, Gaal LV, Callewaert N, Vlierberghe HV.

Dig Liver Dis. 2012 Apr;44(4):315-22. doi: 10.1016/j.dld.2011.10.015. Epub 2011 Nov 25.

PMID:
22119618
20.

High triglyceride levels alter the correlation of apolipoprotein B with low- and non-high-density lipoprotein cholesterol mostly in individuals with diabetes or metabolic syndrome.

Barkas F, Elisaf M, Liberopoulos E, Liontos A, Rizos EC.

Atherosclerosis. 2016 Apr;247:58-63. doi: 10.1016/j.atherosclerosis.2016.02.001. Epub 2016 Feb 10.

PMID:
26868509

Supplemental Content

Support Center